Patent Classification

Treatment, Amenorrhea

1. Drugs for spinal anesthesia
    
2. Topical oestroprogestational compositions with a systemic effect
    
3. Progestin therapy for maintaining amenorrhea

Treatment, Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease

1. Methods for slowing familial ALS disease progression
    
2. Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
    
3. Therapeutic agent for amyotrophic lateral sclerosis (ALS)
    
4. Method for treating amyotrophic lateral sclerosis

Treatment, Androgen-Dependent Disorders

1. Method of treating androgen-dependent disorders
    
2. Use of 4-androstene-3alpha,17 beta-diol to increase testosterone levels in humans
    
3. Methods of treating androgen deficiency in men using selective antiestrogens

Treatment, Anemia

1. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
    
2. In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
    
3. Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
    
4. Use of hepcidin as a regulator of iron homeostasis
    
5. Composition and method for treating autoimmune hemolytic anemia
    
6. Method of treating anemia by administering IL-1ra
    
7. Stimulation of hematopoiesis by ex vivo activated immune cells
    
8. Erythropoietin solution preparation
    
9. Method for iron delivery to a patient by transfer from dialysate
    
10. Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
     
11. Recombinant human erythropoietin with advantageous glycosylation profile
     
12. Methods of treating disease using recombinant adeno-associated virus virions administered to muscle

Treatment, Anesthesia

1. Method of anesthesia
    
2. High-concentration lidocaine compositions and methods for their preparation
    
3. Assessment of concentration of inhalational compounds in the brain
    
4. Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole
    
5. Use of melatonin analogues for induction of general anesthesia
    
6. Assessment of concentration of inhalational compounds in the brain
    
7. Use of melatonin for induction of general anesthesia

Treatment, Angina

1. Methods and composition based on discovery of metabolism of nitroglycerin
    
2. Materials and methods for the treatment of hypertension and angina
    
3. Methods and compositions for the rapid and enduring relief of inadequate myocardial function
    
4. Chrono delivery formulations and method of use thereof
    
5. Pharmaceutical formulations for preventing drug tolerance
    
6. Methods and materials for diagnosing unstable angina
    
7. Nitroglycerin-menthol potentiation for treatment of angina
    
8. Methods for treating angina with ranolazine

Treatment, Angiogenesis/Vasculogenesis

1. JNK3 as a target for the treatment of angiogenesis-related diseases
    
2. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
    
3. Antagonists and methods for inhibiting angiogenesis
    
4. Anti-pleiotrophin antibodies and methods of use thereof
    
5. Methods of screening agents for activity using teleosts
    
6. Methods and compositions for inhibiting angiogenesis
    
7. Methods of screening agents for activity using teleosts
    
8. Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
    
9. Antibodies with immune effector activity and that internalize in endosialin-positive cells
    
10. Compositions and methods for promoting myocardial and peripheral angiogenesis
     
11. Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
     
12. Methods and compositions for the treatment of angiogenic diseases
     
13. Methods of screening agents for activity using teleosts
     
14. .beta.-2-glycoprotein is an inhibitor of angiogenesis
     
15. Small peptides having anti-angiogenic and endothelial cell inhibition activity
     
16. Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis
     
17. Methods for treating or preventing angiogenesis-dependent symptoms
     
18. Methods and compositions for screening for angiogenesis modulating compounds
     
19. Nicotine in therapeutic angiogenesis and vasculogenesis
     
20. Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
     
21. Liposomal camptothecins and uses thereof
     
22. Povidone-containing carriers for polypeptide growth factors
     
23. Attenuation of tumor growth, metastasis and angiogenesis
     
24. Method for promoting neovascularization
     
25. Methods and compositions for inhibiting angiogenesis
     
26. Methods and compositions for screening for angiogenesis modulating compounds
     
27. Methods for detecting and inhibiting angiogenesis
     
28. Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
     
29. Treatment of angiogenesis dependent conditions with dextrin sulphate
     
30. Compositions and methods for inhibiting angiogenesis
     
31. Multiple site delivery of adenoviral vector directly into muscle for the induction of angiogenesis
     
32. Therapeutic compositions and methods for enhancing angiogenesis
     
33. Nicotine in therapeutic angiogenesis and vasculogenesis

Treatment, Anorectal Related Disorders

1. Compositions and methods for the treatment of anorectal disorders

Treatment, Anthrax

1. Antibodies that bind B. anthracis exotoxin, formulations thereof, and methods of use
    
2. Bacillus anthracis protective antigen nucleic acid sequences
    
3. Antibodies with increased affinities for anthrax antigens
    
4. Process for the preparation of non-toxic anthrax vaccine
    
5. Human monoclonal antibodies against Bacillus anthracis protective antigen
    
6. Protein molecule useful for inhibition of anthrax toxin
    
7. Receptor for B anthracis toxin
    
8. Method of making a vaccine for anthrax

Treatment, Anticholinesterase Therapy

1. Method of screening for genetic predisposition to anticholinesterase therapy

Treatment, Anticoagulant

1. Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI)
    
2. Protein for blocking platelet adhesion
    
3. Sulfated hyaluronic acid and esters thereof

Treatment, Antidepression

1. Delivery of antidepressants through an inhalation route
    
2. Methods for assaying for antidepressant therapy markers
    
3. Method to determine the risk for side effects of an SSRI treatment in a person
    
4. Depression gene
    
5. Osmotic device containing venlafaxine and an anti-psychotic agent
    
6. Controlled release oral dosage form
    
7. Hydrogel-driven layered drug dosage form
    
8. Omega-3 fatty acids in the treatment of depression
    
9. Low water-soluble venlafaxine salts
    
10. Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
     
11. Anti-depressant, stress suppressor and mood improver
    
    
12. Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them
    
    
13. Treating depression with alcohol extracts of tobacco
    
    
14. Patch and method for transdermal delivery of bupropion base
     
    
15. St. John's wort composition

Treatment, Antitussive/Antihistamine

1. Composition comprising a tramadol material and acetaminophen and its use
    
2. Antihistamine composition
    
3. Antihistaminic/antitussive compositions
    
4. Antitussive/antihistaminic compositions
    
5. Hydrocodone therapy
    
6. Transdermally administered dextromethorphan as antitussive agent

Treatment, Anxiety/Stress Related Disorders

1. Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
    
2. Dipeptidyl peptidase IV inhibitors for the treatment of anxiety
    
3. Process for effecting the relaxation of muscles of a human by means of fragrance
    
4. Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions
    
5. Alprazolam inclusion complexes and pharmaceutical compositions thereof
    
6. Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal
    
7. Treatment of neurotic disorders
    
8. Delivery of diazepam through an inhalation route
    
9. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
    
10. Methods and compositions for treating generalized anxiety disorder
    
    
11. Mineral and vitamin combinations for the treatment of stress and allergies
     
    
12. Techniques for treating anxiety disorders by brain stimulation and drug infusion

Treatment, Apnea

1. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron

Treatment, Arthritis/Rheumatoid Arthritis/Osteoarthritis/Carpel Tunnel Syndrome

1. Method of treating rheumatoid arthritis with an IL-6R antibody
    
2. Assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6
    
3. Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
    
4. Genomic DNAs participating in rheumatoid arthritis, method of diagnosing the same, method of judging onset risk and diagnostic kit for detecting the same
    
5. Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
    
6. Methods of treating rheumatoid arthritis with anti-TNF antibodies
    
7. Methods for treating pain associated with arthritis
    
8. Use of an IL-1 antagonist for treating arthritis
    
9. Use of erythropoietin in the treatment of rheumatoid arthritis
    
10. Gene therapy using TGF-.beta.
     
11. Sphingomyelin enhancement of tumor therapy
     
12. Mixed-cell gene therapy
     
13. Use of insulin for the treatment of cartilaginous disorders
     
14. Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology
     
15. Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
     
16. Methods of treating rheumatoid arthritis with anti-TNF antibodies
     
17. Methods for treating arthritis pain
     
18. Method of treating musculoskeletal and connective tissue inflammations
     
19. Antibody reactive with a protein having pre-B cell growth-supporting ability
     
20. Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
     
21. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
     
22. Mixed-cell gene therapy
     
23. Treatment of inflammatory disease
     
24. Method for topical treatment of carpal tunnel syndrome
     
25. Method for the treatment of inflammatory disorders
     
26. Solid formulation of glucosamine sulphate
     
27. Methods and materials for evaluating rheumatoid arthritis
     
28. Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
     
29. Use of polysulphated cyclodextrins for treating osteoarthritis
     
30. Treating arthritis in animals with dietary supplements
     
31. Use of jellyfish collagen (type II) in the treatment of rheumatoid arthritis
     
32. Means and methods for fibroblast-like or macrophage-like cell transduction
     
33. Osteoarthritis cartilage regeneration
     
34. Use of IL-12 antagonists in the treatment of rheumatoid arthritis
     
35. Rheumatoid arthritis markers
     
36. 3-phosphoadenosine-5-phosphosulfate (PAPS) synthetase proteins and methods for treating osteoarthritic disorders
     
37. Pain reliever and method of use
     
38. Gene therapy using TGF-.beta
     
39. Use of .DELTA.5-androstene-3.beta.-OL7,17-dione in the treatment of arthritis
     
40. TNF.alpha. antagonists and cyclosporin in therapy of rheumatoid arthritis
     
41. Treatment for reactive arthritis or bursitis
     
42. Therapy for cellular accumulation in chronic inflammatory diseases
     
43. Method for diagnosing bone dysbolism
     
44. Process for preparing an oral suspension of a pharmaceutical substance
     
45. Analgesics combined with naturally-occurring chondroprotective agents
     
46. Chondroitin sulphate and chitosan compositions for treating rheumatic disorders
     
47. Methods and materials for evaluating rheumatoid arthritis
     
48. Composition for the treatment of osteoarthritis
     
49. Synthetic peptide for treatment of autoimmune arthritis
     
50. Method and product using sturgeon notochord for alleviating the symptoms of arthritis
     
51. Peptides binding to bone marrow stromal cell antigen
     
52. Treatment of arthritis and other similar conditions
    
    
53. Method for alleviating arthritis in mammals
    
    
54. Use of fluorocarbons for diagnosis and treatment of articular disorders
    
    
55. Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine
    
    
56. Herbal chinese joint complex
    
    
57. Method and composition for treating arthritis
    
    
58. Herbal-based pharmaceutical formulations
     
    
59. Therapeutic composition including plantain and aloe vera for treatment of arthritis and other afflictions

Treatment, Arthropod-Transmitted Illnesses

1. Recombinant nonstructural protein subunit vaccine against flaviviral infection

Treatment, Asthma/Obstructive Bronchopneumopathies

1. Immunostimulatory nucleic acids for the treatment of asthma and allergy
    
2. Treatment for asthma with .alpha.4-specific antibodies
    
3. Medicaments for asthma treatment
    
4. Methods of treating asthma by administering interleukin-17 receptor
    
5. HFA suspension formulations containing an anticholinergic
    
6. Interleukin-9 mutein peptides
    
7. Combination particles for the treatment of asthma
    
8. Method of testing for bronchial asthma
    
9. Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
    
10. Composition and method for the prevention and treatment of asthma
     
11. Medicine response assay in respiratory disease
     
12. Diagnosis of chronic obstructive pulmonary disease
     
13. High storage stability inhalable compositions
     
14. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
     
15. Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease
     
16. Herbal composition for treating asthma
     
17. Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
     
18. Use of mometasone furoate for treating airway passage and lung diseases
     
19. Bronchodilating compositions and methods
     
20. Methods of treating asthma with interleukin-9 receptor antibodies
     
21. Methods for the screening of non-recombinant cell lines capable of expressing a single PDE4 isoenzyme and for the screening of PDE4 inhibitors
     
22. Methods and compounds for the treatment of mucus hypersecretion
     
23. Herbal remedies for treating allergies and asthma
     
24. Method for treating bronchial constriction and bronchospasm
     
25. Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown
     
26. Mixtures of oxygen and helium for the treatment of respiratory insufficiency
     
27. Metered dose inhaler for beclomethasone dipropionate
     
28. Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
     
29. Formulations for detecting asthma
     
30. Antithrombin agents in treatment of asthma
    
    
31. Methods for treatment of asthma using S-oxybutynin
     
    
32. Methods and compositions for treatment of asthma
     
    
33. Methods of treating asthma with interleukin-9 antibodies

Treatment, Atherosclerosis

1. Peptide-based passive immunization therapy for treatment of atherosclerosis
    
2. Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
    
3. Core 2 .beta.(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis
    
4. Preparation for the prophylaxis of restenosis
    
5. Disease markers for early stage atherosclerosis
    
6. Antibody immunization therapy for treatment of atherosclerosis
    
7. Use of collagenase to facilitate guide wire crossing in total arterial occlusions
    
8. Treatment of atherosclerotic disorders
    
9. Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
    
10. Therapeutic uses of Dunaliella powder
     
11. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
     
12. Orally administered peptides to ameliorate atherosclerosis
     
13. Combined therapies for atherosclerosis treatment
     
14. MCP-1 receptor antibodies
     
15. Liposome compositions and methods for the treatment of atherosclerosis
     
16. Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
     
17. Method for identifying active anti apoptosis compounds
     
18. Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
     
19. Target for treating athersclerosis, obesity and type II diabetes
     
20. Prevention of atherosclerosis and restenosis
     
21. Lipid hydrolysis therapy for atherosclerosis and related diseases
     
22. Plasmid-based vaccine for treating atherosclerosis
     
23. Charged lipid compositions and methods for their use
     
24. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
     
25. Compositions and methods for the prevention and treatment of cardiovascular diseases
     
26. Gene therapy method for reducing risk of atherosclerosis
     
27. Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
     
28. Methods and materials for protecting against myocardial cell damage related to coronary intervention by regional beta blocker therapy
     
29. Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
     
30. Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
     
31. Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
     
32. Dutasteride to prevent and treat atherosclerosis
     
33. Synergistic compositions for lycopene and Vitamin E for the prevention of LDL oxidation
     
34. Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis
     
35. Phospholipid complexes of proanthocyanidin A2 as antiatherosclerotic agents
     
36. Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
    
    
37. Combination therapy for treating hypercholesterolemia
    
    
38. Methods for implanting cells
    
    
39. Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis

Treatment, Attention Deficit Disorder/Hyperactivity

1. Method for treating pervasive development disorders
    
2. Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
    
3. Treatment for attention-deficit hyperactivity disorder
    
4. Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
    
5. Pharmaceutical solutions of modafinil compounds
    
6. Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
    
7. Methods for treating pervasive development disorders
    
8. Method and synergistic composition for treating attention deficit/hyperactivity disorder
    
9. Methods for treating pervasive development disorders
    
10. Alkali or alkaline earth metal of n-butyric acid for treatment of cognitive and emotional conditions
     
11. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
    
    
12. Methods of treating and preventing attention deficit disorders

Treatment, Auditory Disorders

1. Composition and method for treatment of otitis externa
    
2. Method for preventing and treating hearing loss using a neurturin protein product
    
   
3. Methods for inducing proliferation in auditory receptor epithelium

Treatment, Autism

1. Identification of etiology of autism
    
2. Compositions and methods relating to reduction of symptoms of autism
    
3. Compositions and methods relating to reduction of symptoms of autism
    
4. Compositions and methods relating to reduction of symptoms of autism
    
5. Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders
    
6. Composition and method for increasing exorphin catabolism to treat autism
    
7. Method for assisting in differential diagnosis and treatment of autistic syndromes
    
8. Compositions and methods relating to reduction of symptoms of autism
    
9. Modulation of in vivo glutamine and lysine levels in the treatment of autism
   
   
10. Method of using secretin for treating autism

Treatment, Autoimmune Disease

1. Diagnostics and therapy of epstein-barr virus in autoimmune disorders
    
2. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
    
3. Use of parasitic biological agents for prevention and control of autoimmune diseases
    
4. Anti-interferon alpha antibodies
    
5. Method and composition for treating immune complex associated disorders
    
6. Therapeutic use of anti-CS1 antibodies
    
7. Autoimmune disease model animal
    
8. Monoclonal antibodies against interleukin-22
    
9. BAFF receptor polypeptides
    
10. Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof
     
11. Humanized anti-CD4 antibody with immunosuppressive properties
     
12. Anti-CD20 antibodies and fusion proteins thereof and methods of use
     
13. Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
     
14. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
     
15. Treatment of osteoporosis and autoimmune disease with astrogorgiadiol
     
16. Internalizing anti-CD74 antibodies and methods of use
     
17. Autoimmune conditions and NADPH oxidase defects
     
18. Antibody fragments to JTT-1 protein and cells secreting such antibody fragments
     
19. Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
     
20. Anti-CD45RB antibodies
     
21. Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
     
22. JTT-1 protein and methods of inhibiting lymphocyte activation
     
23. Drug therapy for celiac sprue
     
24. Antibodies to JTT-1 protein and cells secreting such antibodies
     
25. Transgenic animal containing CD200 and uses therefor
     
26. Diagnostics and therapy of epstein-barr virus in autoimmune disorders
     
27. Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
     
28. Anti-CD20 antibodies and fusion proteins thereof and methods of use
     
29. Composition and method for treating autoimmune hemolytic anemia
     
30. Anti-interferon-.alpha. antibodies
     
31. Method of treatment using interferon-tau
     
32. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
     
33. Treatment of demyelinating autoimmune disease with ordered peptides
     
34. Autoimmune disease model animal
     
35. DNA vaccination for treatment of autoimmune disease
     
36. Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies
     
37. Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
     
38. Methods and compositions for modulating autoimmunity
     
39. Cyclosporin-based pharmaceutical compositions
     
40. Detection of antibody mediated inflammatory auto-immune disorders
     
41. Methods of using antibodies to human receptor protein 4-1BB
     
42. Compositions and methods for the treatment or prevention of autoimmune diabetes
     
43. Therapeutic chemokine receptor antagonists
     
44. Methods for protecting against autoimmune diabetes
     
45. Cells expressing fusion proteins of immunoglobulins
     
46. Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
     
47. Diagnostic drugs for autoimmune diseases
     
48. Use of coxiella bacteria to treat autoimmune disease
     
49. Anti-GPIIb/IIIa recombinant antibodies
     
50. Preventives/remedies for autoimmune demyelinating diseases
     
51. Materials and methods for treating autoimmune disease
    
    
52. Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
     
    
53. Process for the preparation of immunomodulatory polysaccharides from aloe
     
    
54. Method for treatment of autoimmune diseases